A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home

RecruitingOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

August 29, 2023

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2025

Conditions
CancerSolid Tumors
Interventions
DRUG

Immunotherapy

Immune checkpoint inhibitors in approved indications

Trial Locations (3)

64046

RECRUITING

CH de Pau, Pau

73011

RECRUITING

CH Metropole Savoie, Chambéry

78200

RECRUITING

CH Francois Quesnay, Mantes-la-Jolie

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY